2_NOI-NIAID-25-2247891 FBO.doc
DOC document 37 KB Posted
- Solicitation number
- NOI-NIAID-25-2247891
About this file
This is a Notice of Intent (NOI) issued by the National Institute of Allergy and Infectious Diseases (NIAID) for the renewal of Enduvo Enterprise Edition PRIVATE Creator Software License. NIAID intends to negotiate on an other-than-full-and-open competition basis with Enduvo Inc. for an annual software license renewal to support their Biovisualization Laboratory, which provides virtual and augmented reality (VR/AR) capabilities for training research and educational preparation.
The renewal period is January 1, 2025 to December 31, 2025, and includes Enterprise Edition License Maintenance, Standard Support 8x5, and NIH-Specific PUBLIC Domain Creator License(s). The requirement is being pursued as a sole source procurement since Enduvo is the exclusive owner of the proprietary software. Capability statements from other potential sources are due by 11:00 AM EST on December 12, 2024, through the NIAID electronic Simplified Acquisition Submission System (eSASS). The opportunity is classified under NAICS code 513210 (Software Publishers) with no set-aside designation. The software has been in use for over 4 years and supports four workstations with high-end computational and graphics processing hardware at the BioViz Lab located at 5601 Fishers Lane.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
NOIPRE-SOLICITATION NOTICE – NOTICE OF INTENT
Document Type: Presolicitation / Notice of Intent
Solicitation Number: NOI-NIAID-25-2247891 Posted Date: 12/2/2024
Response Date: 12/12/2024 Set Aside: No
NAICS Code: 513210 (Software Publishers) Classification Code: 7A21 Contracting Office Address:
Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases, 5601 Fishers Lane, Rockville, MD 20852
Title: Enduvo Enterprise Licenses, Maintenance and Support Renewal
| Primary Point of Contact: |
| Secondary Point of Contact |
| Kimberly.rubio@nih.gov |
| Talexander@niaid.nih.gov |
Description:
This is a Notice of Intent, NOT a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Enduvo Inc., 2601 W. Lake Avenue, Suite A6-110, Peoria, Illinois 61615, to procure an annual renewal of Enduvo Enterprise Edition PRIVATE Creator Software License, proprietary in nature, to the support of the established the NIAID Biovisualization Laboratory.
The NIAID, Bioinformatics and Computational Biosciences Branch is seeking to purchase an annual renewal of the Enduvo software platform, which is used in creating virtual and augmented reality (VR/AR) for training research and educational preparation in the NIAID Biovisualization Laboratory. This is a program aimed toward developing a dedicated facility to provide NIAID staff with various options for advanced visualization experiences. Currently located at 5601 Fishers Lane, the BioViz Lab hosts four workstations, each with high-end computational and graphics processing hardware to support the most advanced requirements of VR and AR devices and applications. This software has been in use for more than 4 plus year, and is the backbone of existing and planned projects. Therefore, this requirement is to continue access to our existing software and concurrent licenses. Enduvo software and all of its component parts are the exclusive property of Enduvo. The licenses are proprietary software which can only be obtained from the manufacturer.
Specifications:
Enduvo Enterprise Edition PRIVATE Creator License includes Enduvo Enterprise Edition License Maintenance, Enduvo Enterprise Edition Standard Support 8x5, NIH-Specific PUBLIC Domain Creator License(s) Platform
Software Renewal Period: 1/1/2025 – 12/31/2025 The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply or service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability by 11:00am - EST, Thursday, December 12, 2024. All capability statements must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit a quotation. Instructions on how to register / submit capability statements are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency.
File details come from the government source that posted it. Updated .